| Pannexin channels and their links to human disease S Penuela, L Harland, J Simek, DW Laird Biochemical Journal 461 (3), 371-381, 2014 | 139 | 2014 |
| Comorbidity and prognosis in head and neck cancers: differences by subsite, stage, and human papillomavirus status S Habbous, LTG Harland, A La Delfa, E Fadhel, W Xu, FF Liu, D Goldstein, ... Head & neck 36 (6), 802-810, 2014 | 84 | 2014 |
| Second-hand smoke as a predictor of smoking cessation among lung cancer survivors L Eng, J Su, X Qiu, PR Palepu, H Hon, E Fadhel, L Harland, A La Delfa, ... Journal of clinical oncology 32 (6), 564-570, 2014 | 65 | 2014 |
| The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre S Habbous, KP Chu, X Qiu, A La Delfa, LTG Harland, E Fadhel, A Hui, ... Cancer epidemiology 37 (6), 820-829, 2013 | 58 | 2013 |
| Inhibition of pannexin 1 reduces the tumorigenic properties of human melanoma cells TJ Freeman, S Sayedyahossein, D Johnston, RE Sanchez-Pupo, ... Cancers 11 (1), 102, 2019 | 41 | 2019 |
| Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients S Habbous, KP Chu, LTG Harland, A La Delfa, E Fadhel, B Sun, W Xu, ... Oral oncology 49 (5), 407-412, 2013 | 37 | 2013 |
| The T-box transcription factor Eomesodermin governs haemogenic competence of yolk sac mesodermal progenitors LTG Harland, CS Simon, AD Senft, I Costello, L Greder, ... Nature cell biology 23 (1), 61-74, 2021 | 6 | 2021 |
| Cancer patients’ acceptability of incorporating an epidemiology questionnaire within a clinical trial S Cuffe, H Hon, K Tobros, O Espin-Garcia, Y Brhane, L Harland, E Fadhel, ... Clinical Trials 12 (3), 237-245, 2015 | 2 | 2015 |
| Eomesodermin governs the hemogenic competence of murine mesodermal progenitors LTG Harland University of Oxford, 2020 | | 2020 |
